Related Experiment Videos
Applications of monoclonal antibodies in clinical oncology
A J George1, R A Spooner, A A Epenetos
1Dept of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Immunology Today
|December 1, 1994
Application of monoclonal antibodies (mAbs) to clinical settings has proved to be slower than originally hoped. However, a recent conference provided evidence that the field is coming of age, and that antibodies, and their recombinant derivatives, will continue to find a role in the clinic.
Application of monoclonal antibodies (mAbs) to clinical settings has proved to be slower than originally hoped. However, a recent conference provided evidence that the field is coming of age, and that antibodies, and their recombinant derivatives, will continue to find a role in the clinic.